Premium Information is available for this item - Upgrade for $1 a day
6505-01-301-3789
Usp Clindamycin Injection
6505013013789 013013789 F91G206 NDC00074-4054-03 NDC00703-9110-04 NDC00469-2820-70 NDC00009-0775-20
January 2023
5
Marketplace 6505-01-301-3789
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-301-3789 5+ Documents (More...)
6505-19-001-0609 Related to 6505-00-509-7903 6505-01-181-8688 6505-42-000-0449 6505-01-187-5540 6505-01-301-3789
6505001388474 Related to 6505-00-138-8474 6505-01-181-8688 6505-42-000-0449 6505-01-187-5540 6505-01-301-3789
Clindamycin Injection 6505001391318 139-1318 6505-01-181-8688 6505-42-000-0449 6505-01-187-5540 6505-01-301-3789
Stock Numbers Related to 6505-00-509-7903 6505-01-181-8688 6505-42-000-0449 6505-01-187-5540 6505-01-301-3789
001-0609 Injection 6505001391318 139-1318 6505-01-181-8688 6505-42-000-0449 6505-01-187-5540 6505-01-301-3789
Stock Numbers Related to 6505-42-000-0449 6505-01-181-8688 6505-42-000-0449 6505-01-187-5540 6505-01-301-3789
Injection 6505005097903 Injection 6505001388474 138-8474 6505-01-181-8688 000-0449 6505-01-187-5540 6505-01-301-3789
Stock Numbers Related to 6505-01-181-8688 6505-01-181-8688 6505-42-000-0449 6505-01-187-5540 6505-01-301-3789
Stock Numbers Related to 6505-33-190-1701 6505-01-181-8688 6505-42-000-0449 6505-01-187-5540 6505-01-301-3789
Restrictions 6505-01-301-3789
6505-01-301-3789 is a Usp Clindamycin Injection that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6505-01-301-3789
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-301-3789
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-301-3789
- Part Number
- Manufacturer
- Status
- NDC00074-4054-03
- Manufacturer
- 60060 - Abbott Laboratories Inc. (Active)
- Primary Buy
- Primary Buy
- NDC00703-9110-04
- 41930 - B Braun Medical Inc (Obsolete)
- Primary Buy
- Primary Buy
- NDC00469-2820-70
- 60567 - Lyphomed Inc Div Of Fujisawa Usa Inc (Obsolete)
- Primary Buy
- Primary Buy
- NDC00009-0775-20
- 93703 - Pharmacia & Upjohn Company (Active)
- Primary Buy
- Primary Buy
- F91G206
- 66735 - Air Force Medical Logistics Office (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-301-3789
- Characteristic
- Specifications
- FIIG
- Specifications
- A45100
- Active Medicament Medicinal Strength [AKJA]
- 150.000 Milligrams Clindamycin Equivalent Per Milliliter
- Administration [CSGS]
- Intramuscular And Intravenous
- Primary Container Content Quantity [CRLK]
- 4.000 Milliliters
- Primary Container Type [CQCT]
- Vial
- Total Primary Container Quantity [CSCW]
- 25
- Supplementary Features [SUPP]
- Medsep Item For Dod,Abbott Lab
Management Data 6505-01-301-3789
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Nov 1989
- Veterans Administration (VA)
- PG
- Subscribe
- PG
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 25 Ea
- 00000000025EA
- K
NATO Stock Numbers Related to 6505-01-301-3789
Freight Information 6505-01-301-3789
6505-01-301-3789 has freight characteristics.. 6505-01-301-3789 has a variance between NMFC and UFC when transported by rail and the description should be consulted.